{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:38:25Z","timestamp":1775018305993,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunosuppressant medications, such as tacrolimus and mycophenolate mofetil (MMF), are crucial for preventing graft rejection after heart transplantation (HTx). Generic formulations have become available, offering potential cost savings, but concerns exist regarding their clinical bioequivalence compared to brand\u2010name formulations. Current guidelines suggest no increased risk with generic use, but research remains limited. Therefore, this study aims to explore whether the type of immunosuppressant formulation at hospital discharge influences post\u2010transplant outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective analysis utilized data from the United Network for Organ Sharing (UNOS) registry, including HTx recipients from January 2015 to March 2022. Patients were grouped based on their discharge immunosuppressant regimen: dual generic, dual brand\u2010name, or a mix of both tacrolimus and MMF. Demographic and clinical variables were collected. The primary outcome was all\u2010cause mortality and graft failure, assessed using Kaplan\u2010Meier analysis and Cox proportional hazards regression. Multivariable Cox regression was adjusted for recipient and donor characteristics. Statistical significance was set at\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.05. This approach allows for a thorough examination of the relationships between immunosuppressant formulations and outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 16\u00a0529 HTx recipients. The majority (52.0%) were discharged on a dual generic regimen. At 1\u2010year post\u2010transplant, significant differences were observed in treatment for rejection, graft failure, and all\u2010cause mortality among the groups. The dual generic group demonstrated the lowest rates of graft failure (13.6%) and all\u2010cause mortality (13.1%) at 5 years. However, after adjusting for demographic and clinical characteristics using multivariable Cox regression, no significant differences in graft failure or mortality were observed among the immunosuppressant regimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite initial differences in unadjusted outcomes, adjusted analyses did not demonstrate a significant difference in graft failure or mortality between brand\u2010name and generic immunosuppressant regimens. These findings suggest that clinicians can confidently prescribe generic immunosuppressants without compromising patient outcomes, potentially leading to substantial healthcare savings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ctr.70196","type":"journal-article","created":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:58:42Z","timestamp":1748779122000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Generic Versus Brand\u2010Name Immunosuppression Following Heart Transplant: An Analysis of the UNOS Database"],"prefix":"10.1111","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7903-6705","authenticated-orcid":false,"given":"Aviral","family":"Mahajan","sequence":"first","affiliation":[{"name":"School of Medicine University of Connecticut  Farmington Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0776-4209","authenticated-orcid":false,"given":"Jiwon","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Statistics University of Connecticut  Storrs Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy E.","family":"Moore","sequence":"additional","affiliation":[{"name":"Statistical Consulting Service Center for Open Research Resources &amp; Equipment University of Connecticut  Storrs Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2172-0931","authenticated-orcid":false,"given":"William L.","family":"Baker","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of Connecticut  Storrs Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9467-334X","authenticated-orcid":false,"given":"Cesar Rodrigo","family":"Zoni","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery University of Connecticut Health Center  Farmington Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0532-8500","authenticated-orcid":false,"given":"Stephen","family":"Akinfenwa","sequence":"additional","affiliation":[{"name":"University of Connecticut Internal Medicine Residency  Farmington Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirghani","family":"Mohamed","sequence":"additional","affiliation":[{"name":"School of Medicine University of Connecticut  Farmington Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7279-2356","authenticated-orcid":false,"given":"Matthew","family":"Dean","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University Health System Internal Medicine Residency  Richmond Virginia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-0209","authenticated-orcid":false,"given":"Chittoor","family":"Sai\u2010Sudhakar","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery University of Connecticut Health Center  Farmington Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1479-7037","authenticated-orcid":false,"given":"Yazhini","family":"Ravi","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery University of Connecticut Health Center  Farmington Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,6]]},"reference":[{"issue":"8","key":"e_1_2_11_2_1","first-page":"484","article-title":"Clinical Outcomes After Conversion From Brand\u2010Name Tacrolimus (Prograf) to a Generic Formulation in Renal Transplant Recipients","volume":"38","author":"Marfo K.","year":"2013","journal-title":"P & T: A Peer\u2010Reviewed Journal for Formulary Management"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14722"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003\u20104819\u2010142\u201011\u2010200506070\u201000006"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10590918"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.05.001"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440390066010"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432\u20102277.2011.01268.x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40697\u2010014\u20100023\u20108"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12564"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.10.015"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.4236\/ojots.2013.32004"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.03.009"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3163"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271\u2010016\u20100176\u2010x"},{"key":"e_1_2_11_16_1","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.884"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1026895"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102022\u2010061689"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102015\u2010008915"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3588"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.11.020"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.5888\/pcd9.120010"},{"issue":"2","key":"e_1_2_11_24_1","article-title":"Regional Disparities in Heart Transplant Mortality in the United States","volume":"11","author":"Zoni C. R.","year":"2024","journal-title":"European Heart Journal \u2010 Quality of Care and Clinical Outcomes"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2016.01.123"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1130"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2019.03.063"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2012-000258"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10590918"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ctr.70196","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ctr.70196","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ctr.70196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:14:02Z","timestamp":1769724842000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ctr.70196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1111\/ctr.70196"],"URL":"https:\/\/doi.org\/10.1111\/ctr.70196","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2025-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70196"}}